Back to top
   Call Me Free Send SMS Send Inquiry
SPARK LIFESCIENCES
Send Inquiry
Erlonat Tablet

Erlonat Tablet

11900 INR/Pack
Get a Price/Quote

Product Details:

  • Drug Type General Medicines
  • Ingredients Erlotinib
  • Physical Form Tablets
  • Recommended For Lung cancer
  • Dosage 150mg
  • Suitable For Adults
  • Storage Instructions Cool Dry Place
  • Supply Ability : 200 Pack Per Week
  • Click to view more
Request To Call Back Send Inquiry
X

Price And Quantity

  • 10 Pack
  • 11900 INR/Pack

Product Specifications

  • Tablets
  • Adults
  • 150mg
  • General Medicines
  • Erlotinib
  • Lung cancer
  • Cool Dry Place

Trade Information

  • mumbai
  • Cash Advance (CA), Cash in Advance (CID), Western Union, Paypal
  • 200 Pack Per Week
  • 15 Days
  • As Per Requirement
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India

Product Description

Erlotinib is used to treat metastatic non-small cell lung cancer, as first line treatment, maintenance treatment, or after failure of one prior chemotherapy. It is also used to treat locally advanced, unresectable (which cannot be removed by surgery), or metastatic (cancer which has spread) pancreatic cancer in combination with another drug called gemcitabine.


How it works


Erlotinib belongs to a class of medications called tyrosine kinase inhibitors. It works by preventing the activity of a protein called epidermal growth factor, and thereby stops the growth and spread of cancer cells.

Enter Buying Requirement Details
+ Add Attachment
Email Id
Mobile number

Other Products in 'Pharmaceutical Tablet' category

Disulfiram Tablets
Send Inquiry
Dasanat Tab
Send Inquiry
Sofosbuvir Tab
Send Inquiry
Levonorgestrel Tab
Send Inquiry
SEND INQUIRY CALL ME FREE


SPARK LIFESCIENCES
B No. 220, Samanvay Silicon, Beside Datta Mandir, Opposite Kalyan Cafe, Sayajigunj,Vadodara - 390020, Gujarat, India
Phone :08045475752
Mr Gaurang Patel (Partner)
Mobile :08045475752
SPARK LIFESCIENCES All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.